Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

Abivax will present nine scientific abstracts on obefazimod at Digestive [...]

Alto Neuroscience has started a Phase 2b trial of ALTO-207 [...]

ARTCLINE has completed patient enrolment in a 142-patient randomized study [...]

Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

Neomorph has closed a $100 million Series B financing to [...]

The National Institute for Health and Care Excellence (NICE) has [...]

Oncodesign Services has expanded its collaboration with French research institute [...]

Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]